Nicola Broughton

Photopharmica Ltd. develops and discovers novel photosensitizer products. Its products pipeline includes phenothiazinium photosensitizers for use as topical therapeutic antimicrobial agents and phthalocyanine photo sensitizers that combine anti-tumor properties with minimal or zero skin photo sensitization. The firm's light-activated drugs kill common disease-causing microorganisms including Gram positive and negative bacteria. The company was founded in 2001 by John Lyon and is headquartered in Leeds, the United Kingdom.

Mercia Fund Management Ltd. (Mercia Fund) is a private equity subsidiary of Mercia Asset Management Plc founded in 1999 by Mark Andrew Payton, Timothy R. Hazell and Everard Mascarenhas. The firm is headquartered in Warwickshire, Great Britain.

Medherant Ltd. develops transdermal drug delivery patches. It offers transdermal drug patches for skin surface and are being used increasingly for pharmaceutical products such as analgesics, alzheimer's, smoking cessation, and hormone therapy. The company was founded by David Haddleton on April 2, 2014 and is headquartered in Coventry, the United Kingdom.

QUBIS Ltd (Qubis) is a venture capital firm, subsidiary of Queen's University of Belfast founded in the year 1984. The firm is headquartered in Belfast, Northern Ireland.

Nodus Oncology Ltd. develops therapies that target DDR (DNA damage response) to treat cancer. The company is based in Edinburgh, UK. The British company was founded in 2020. The CEO is Ian David Waddell.

Wobble Genomics Ltd. develops DNA normalization technology to maximize sampling efficiency during sequencing. The company is based in Edinburgh, UK.

Cumulus Oncology Ltd. develops oncology drugs. The company was founded by Clare Wareing on November 13, 2017 and is headquartered in Edinburgh, the United Kingdom.

Cytomos Ltd. provides rapid label-free cell analysis for biotechnology research and in-vitro diagnostics using dielectric spectroscopy. The firm offers ePad technology which permits detection, identification, and characterization of single cells in real-time as they progress through an experiment. The company was founded by Keith Muir and is headquartered in Edinburgh, the United Kingdom.

Oskare Capital SAS is an Independent firm. Oskare Capital SAS is headquartered in Paris, France.